Shares of Aurora Cannabis (TSX:ACB) rallied on Monday (September 17) after a report indicated the company was the target partner for The Coca-Cola Company (NYSE:KO) for the development of wellness beverages infused with CBD.

The report from BNN Bloomberg indicated the partnership between Aurora and the beverage giant would seek to develop “beverages that will ease inflammation, pain and cramping.”


Unnamed sources said in the report the deal was “pretty advanced down the path” and would target the wellness market.

Stocks for Aurora closed Monday’s trading session with a whopping 16.86 percent increase in value from its previous closing price. ACB finished with a price per share of C$9.98.

Coca-Cola shares on the New York Stock Exchange also rose following the report. The share price for Coca-Cola raised to $46.32, representing a 0.72 percent hike.

During after hours trading, shares of the beverage company were up 0.32 percent on top of its closing price.

The massive beverage company behind popular sodas like Coke, Sprite and Dasani water counts with a US$197 billion market cap.

According to the report, representatives from Coca-Cola also met with Aphria (TSX:APH). However, conversations with the licensed producer (LP) didn’t advance much after.

Coca-Cola confirms interest in “non-psychoactive CBD”

After speculation ran rampant on Monday, Coca-Cola issued a statement in an attempt to clarify the rumors.

“We have no interest in marijuana or cannabis. Along with many others in the beverage industry, we are closely watching the growth of non-psychoactive CBD as an ingredient in functional wellness beverages around the world. The space is evolving quickly. No decisions have been made at this time.”

Beverage companies seek potential in cannabis market

If confirmed, the move by Coca-Cola would continue a trend of established beverage companies seeking or obtaining entries into the emerging cannabis space.

Most recently, rumors circled of alcohol producer Diageo (NYSE:DEO) seeking some form of partnership with one of the Canadian licensed producers.

Doug Waterson, CFO and portfolio manager with Faircourt Asset Management and manager of the Ninepoint UIT Alternative Health Fund told the Investing News Network (INN) a majority of the rally for Tilray was due to its leading position as the company set to win the partnership with Diageo.

Last year, Constellation Brands (NYSE:STZ) became the first alcohol producer to get involved with the public cannabis space directly following an investment deal into Canopy Growth (NYSE:CGC,TSX:WEED).

In August, that relationship showed its evolution as Constellation Brands re-upped in Canopy supplying the producer with a C$5 billion investment to help the company expand international opportunities.

“Over the past year, we’ve come to better understand the cannabis market, the tremendous growth opportunity it presents, and Canopy’s market-leading capabilities in this space,” Rob Sands, CEO of Constellation Brands said.

The partnership between these two is also set to develop cannabis infused beverages.

Charles Taerk, president and CEO of Faircourt Asset Management, told INN the move from Constellation brought legitimacy to the cannabis space and made him ask himself which company was next for a partnership.

“[There is a] list of companies that we feel are well positioned, have capacity and don’t have a dance partner, so it’s potential,” Taerk said.

The other alcohol company to enter the cannabis space was Molson Coors Brewing (NYSE:TAP,TSX:TPX). The company formed a joint venture with cannabis Quebec-based LP HEXO (TSX:HEXO), formerly known as The Hydropothecary Corporation.

The new entity will also seek to develop non-alcoholic beverages infused with cannabis.

Investor takeaway

The entry from another beverage company into the cannabis space would only help to improve the legitimation process the industry has embarked on this year as legalization is weeks away in Canada.

Pressure for beverage companies to diversify and find new revenue streams has also been at the centre of these moves into the cannabis space.

Don’t forget to follow us @INN_Cannabis for real-time news updates and stay tuned for cannabis stories from the MoneyShow!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Centurion to acquire a Disruptive Water-Soluble Cannabinoid Technology Platform Delivering Rapid Onset, Increased Bioavailability, Premium Taste Profiles and Highly Competitive Cost Structure

Centurion Minerals Ltd. (TSXV: CTN) (FSE: XJCB) (“Centurion” or the “Company”) is pleased to announce that it has entered into an Amalgamation Agreement dated February 17, 2021 (the “Agreement”), with HAI Beverages Inc. (“HAI”), whereby Centurion will acquire 100% of the outstanding shares and assets of a wholly-owned subsidiary of HAI (“NewHAI) in exchange for common shares of Centurion (the “Acquisition” or “Transaction”). NewHAI holds all material assets of HAI and the Acquisition will constitute a reverse take-over (“RTO”) of the Company.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today its participation in the following investor conferences:

  • Needham 2nd Annual Virtual Cannabis Conference – March 3 rd , 2021 – Management will participate in virtual one-on-one meetings.
  • 33rd Annual Roth Conference – March 15 th -17 th , 2021 – Charlie Bachtell, CEO and Co-Founder, will participate in a Fireside Chat and management will later participate in virtual one-on-one meetings on April 7 th .
  • Stifel Multi-Sector Conference – April 21 st , 2021 – Management will participate in virtual one-on-one meetings.

About Cresco Labs

Keep reading... Show less

Green Thumb Industries, a leading cannabis consumer packaged goods company and owner of Rise™ Dispensaries, is expanding key partnerships and creating scholarships earmarked for those from communities most impacted by the war on drugs as part of its corporate social responsibility program. The scholarships will be granted to a total of four students for programs at the Cleveland School of Cannabis in Ohio and Olive-Harvey College in Illinois. Additionally, Green Thumb will continue its support of Cabrini Green Legal Aid and partner with the North Lawndale Employment Network in Chicago as part of ongoing collaborations that include financial support, volunteerism and awareness initiatives.

Building on the foundation of Green Thumb’s LEAP initiative, which provided pro-bono support for social equity license applicants in Illinois and which will soon offer business incubator resources to newly awarded social equity entrepreneurs, these impactful partnerships mark a critical next step in prioritizing diversity, equity, and inclusion in the cannabis industry.

Keep reading... Show less

All five flavours of the Company’s KOIOS™ nootropic beverage product are now being carried by Jensen’s, a regional supermarket chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. This placement of KOIOS™ follows several other recent placements of the Company’s beverage products in regional supermarket chains across the United States as part of a strategy to passively build market share in specific geographical areas.

Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that the full range of five flavours of its KOIOS ™ nootropic beverages can now be purchased at all grocery stores operated by Jensen’s Foods (“Jensen’s”), a long-established family-owned grocery chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. In a press release dated February 19, 2021 the Company announced another chain-wide placement of KOIOS ™ nootropic beverages on the west coast of the United States with Market of Choice in Oregon. With this placement of KOIOS ™ in Jensen’s supermarkets, the Company’s beverage products are now carried in approximately 180 retail stores on the west coast, out of a total of more than 4,000 retail stores nationwide.

Keep reading... Show less

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less